These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 31281017)
1. Corrigendum to "Aegeline, a natural product from the plant Aegle marmelos, mimics the yeast SNARE protein Sec22p in suppressing α-synuclein and Bax toxicity in yeast" [Bioorg. Med. Chem. Lett. 29 (2019) 454-460]. Derf A; Sharma A; Bharate SB; Chaudhuri B Bioorg Med Chem Lett; 2019 Aug; 29(16):2437-2438. PubMed ID: 31281017 [No Abstract] [Full Text] [Related]
2. Aegeline, a natural product from the plant Aegle marmelos, mimics the yeast SNARE protein Sec22p in suppressing α-synuclein and Bax toxicity in yeast. Derf A; Sharma A; Bharate SB; Chaudhuri B Bioorg Med Chem Lett; 2019 Feb; 29(3):454-460. PubMed ID: 30579794 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous Determination of Aegeline and Six Coumarins from Different Parts of the Plant Aegle marmelos Using UHPLC-PDA-MS and Chiral Separation of Aegeline Enantiomers Using HPLC-ToF-MS. Avula B; Chittiboyina AG; Wang YH; Sagi S; Raman V; Wang M; Khan IA Planta Med; 2016 Apr; 82(6):580-8. PubMed ID: 27054911 [TBL] [Abstract][Full Text] [Related]
4. Aegeline from Aegle marmelos stimulates glucose transport via Akt and Rac1 signaling, and contributes to a cytoskeletal rearrangement through PI3K/Rac1. Gautam S; Ishrat N; Singh R; Narender T; Srivastava AK Eur J Pharmacol; 2015 Sep; 762():419-29. PubMed ID: 26102565 [TBL] [Abstract][Full Text] [Related]
6. Effects of aegeline, a main alkaloid of Aegle Marmelos Correa leaves, on the histamine release from mast cells. Nugroho AE; Riyanto S; Sukari MA; Maeyama K Pak J Pharm Sci; 2011 Jul; 24(3):359-67. PubMed ID: 21715270 [TBL] [Abstract][Full Text] [Related]
7. Anti adipogenic activity of Aegle marmelos Correa. Karmase A; Jagtap S; Bhutani KK Phytomedicine; 2013 Nov; 20(14):1267-71. PubMed ID: 23972792 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents. Manda VK; Avula B; Chittiboyina AG; Khan IA; Walker LA; Khan SI Xenobiotica; 2016; 46(2):117-25. PubMed ID: 26247834 [TBL] [Abstract][Full Text] [Related]
9. Corrigendum to "Protein ligand-tethered synthetic calcium indicator for localization control and spatiotemporal calcium imaging in plant cells" [Bioorg. Med. Chem. Lett. 26 (2016) 9-14]. Takaoka Y; Shigenaga M; Imai M; Nukadzuka Y; Ishimaru Y; Saito K; Yokoyama R; Nishitani K; Ueda M Bioorg Med Chem Lett; 2016 Jun; 26(12):2974. PubMed ID: 27161279 [No Abstract] [Full Text] [Related]
10. Acute and subacute toxicity studies of Aegle marmelos Corr., an Indian medicinal plant. Veerappan A; Miyazaki S; Kadarkaraisamy M; Ranganathan D Phytomedicine; 2007 Feb; 14(2-3):209-15. PubMed ID: 16860551 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of aldose reductase by Aegle marmelos and its protective role in diabetic cataract. Sankeshi V; Kumar PA; Naik RR; Sridhar G; Kumar MP; Gopal VV; Raju TN J Ethnopharmacol; 2013 Aug; 149(1):215-21. PubMed ID: 23827758 [TBL] [Abstract][Full Text] [Related]
12. Corrigendum to "A novel intestinal-restricted FXR agonist" [Bioorg Med Chem Lett 27 (2017) 3386-3390]. Wang H; Zhao Z; Zhou J; Guo Y; Wang G; Hao H; Xu X Bioorg Med Chem Lett; 2017 Dec; 27(23):5353. PubMed ID: 29110987 [No Abstract] [Full Text] [Related]
13. Corrigendum to "Dimeric sesquiterpene and thiophenes from the roots of Echinops latifolius" [Bioorg. Med. Chem. Lett. 26 (2016) 5995-5998]. Jin Q; Lee JW; Jang H; Choi JE; Kim HS; Lee D; Hong JT; Lee MK; Hwang BY Bioorg Med Chem Lett; 2017 Mar; 27(6):1490. PubMed ID: 28202326 [No Abstract] [Full Text] [Related]
14. Corrigendum to "A selective delta opioid receptor antagonist based on a stilbene core" [Bioorg. Med. Chem. Lett. 25 (2015) 5532-5535]. Hartung AM; Navarro HA; Wiemer DF; Neighbors JD Bioorg Med Chem Lett; 2016 Mar; 26(6):1645. PubMed ID: 28750745 [No Abstract] [Full Text] [Related]
15. Corrigendum to "Investigation of biaryl heterocycles as inhibitors of Wee1 kinase" [Bioorg. Med. Chem. Lett. 29 (2019) 1481-1486]. Mastracchio A; Lai C; Torrent M; Bromberg K; Buchanan FG; Ferguson D; Bontcheva V; Johnson EF; Lasko L; Maag D; Shoemaker AR; Penning TD Bioorg Med Chem Lett; 2020 Feb; 30(4):126895. PubMed ID: 31926787 [No Abstract] [Full Text] [Related]
16. Corrigendum to "Rotenoisin A is a novel anti-adipogenic compound" [Bioorg. Med. Chem. Lett. 29 (2018) 89-96]. Cho HH; Park HS; Jang SH; Won C; Kim HD; Kim TH; Cho JH Bioorg Med Chem Lett; 2020 Aug; 30(16):127295. PubMed ID: 32571641 [No Abstract] [Full Text] [Related]
17. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431]. Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309 [No Abstract] [Full Text] [Related]
18. Corrigendum to "Preventive effect of a novel diosgenin derivative on arterial and venous thrombosis in vivo" [Bioorg. Med. Chem. Lett. 26 (2016) 3364-3369]. Zheng H; Wei Z; Xin G; Ji C; Wen L; Xia Q; Niu H; Huang W Bioorg Med Chem Lett; 2016 Sep; 26(17):4386. PubMed ID: 27474444 [No Abstract] [Full Text] [Related]
19. Corrigendum to 'Easy and rapid preparation of benzoylhydrazides and their diazene derivatives as inhibitors of 15-lipoxygenase' [Bioorg. Med. Chem. Lett. 27 (2017) 1649-1653]. Tirapegui C; Acevedo-Fuentes W; Dahech P; Torrent C; Barrias P; Rojas-Poblete M; Mascayano C Bioorg Med Chem Lett; 2017 Sep; 27(17):4218. PubMed ID: 28780158 [No Abstract] [Full Text] [Related]
20. Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870]. Arslan T; Türkoğlu EA; Şentürk M; Supuran CT Bioorg Med Chem Lett; 2017 Aug; 27(16):3944. PubMed ID: 28705642 [No Abstract] [Full Text] [Related] [Next] [New Search]